Related Articles
Anti‑angiogenesis gene therapy for hepatocellular carcinoma via systemic injection of mesenchymal stem cells engineered to secrete soluble Flt‑1
VEGF blockade decelerates the growth of a murine experimental osteosarcoma
Recombinant human vascular endothelial growth factor receptor 1 effectively inhibits angiogenesis in vivo
VEGF-subtype specific protection of SCC and HUVECs from radiation induced cell death
8-(3-oxo-4,5,6-trihydroxy-3h-xanthen-9-yl)-1-naphthoic acid inhibits MAPK phosphorylation in endothelial cells induced by VEGF and bFGF.